Video Experimental Relacionado
Updated: Jan 13, 2026
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
Published on: January 14, 2020
Modelos de organoides para predecir la respuesta a la quimioterapia y guiar la estrategia quirúrgica en el cáncer de
Hasibullah Aminpoor1, Muhammad Zaib2, Muhammad Khizar2
1Faculty of Medicine, Kabul University of Medical Sciences "Abu Ali Ibn Sina", Kabul, Afghanistan.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, with limited predictive biomarkers for chemotherapy response. Patient-derived organoids (PDOs), developed from endoscopic or surgical samples, faithfully replicate tumor genetics and microarchitecture, allowing rapid ex vivo drug testing. Early studies from the United States, Japan, and Europe demonstrate that PDO chemosensitivity strongly correlates with clinical response, enabling personalized preoperative strategies. PDO-guided chemotherapy could refine neoadjuvant selection, minimize ineffective regimens, and inform optimal surgical timing. This translational advance represents a promising shift toward precision surgery in PDAC, warranting international standardization and integration into multidisciplinary workflows.
